Clinical Trial Update: Exploratory Study of the Effects of Vortioxetine (Lu AA21004) on Cognition and Blood Oxygen Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signals in Subjects Remitted From Depression and in Controls [Phase 1]

View source ↗

Summary

Phase 1 exploratory study assessing how vortioxetine affects cognition and BOLD fMRI signals in individuals remitted from depression and in controls.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Depression | Phase 1 | Status: COMPLETED